1. Home
  2. ABCL vs LC Comparison

ABCL vs LC Comparison

Compare ABCL & LC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • LC
  • Stock Information
  • Founded
  • ABCL 2012
  • LC 2006
  • Country
  • ABCL Canada
  • LC United States
  • Employees
  • ABCL N/A
  • LC N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • LC Finance: Consumer Services
  • Sector
  • ABCL Health Care
  • LC Finance
  • Exchange
  • ABCL Nasdaq
  • LC Nasdaq
  • Market Cap
  • ABCL 1.1B
  • LC 1.5B
  • IPO Year
  • ABCL 2020
  • LC 2014
  • Fundamental
  • Price
  • ABCL $4.72
  • LC $15.39
  • Analyst Decision
  • ABCL Strong Buy
  • LC Buy
  • Analyst Count
  • ABCL 5
  • LC 6
  • Target Price
  • ABCL $8.75
  • LC $17.00
  • AVG Volume (30 Days)
  • ABCL 6.8M
  • LC 1.6M
  • Earning Date
  • ABCL 08-07-2025
  • LC 07-29-2025
  • Dividend Yield
  • ABCL N/A
  • LC N/A
  • EPS Growth
  • ABCL N/A
  • LC 28.90
  • EPS
  • ABCL N/A
  • LC 0.44
  • Revenue
  • ABCL $23,114,000.00
  • LC $1,195,590,000.00
  • Revenue This Year
  • ABCL N/A
  • LC N/A
  • Revenue Next Year
  • ABCL $71.11
  • LC $19.23
  • P/E Ratio
  • ABCL N/A
  • LC $29.45
  • Revenue Growth
  • ABCL N/A
  • LC 8.77
  • 52 Week Low
  • ABCL $1.89
  • LC $7.90
  • 52 Week High
  • ABCL $5.82
  • LC $18.75
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 60.66
  • LC 79.83
  • Support Level
  • ABCL $4.64
  • LC $12.65
  • Resistance Level
  • ABCL $5.19
  • LC $13.42
  • Average True Range (ATR)
  • ABCL 0.40
  • LC 0.53
  • MACD
  • ABCL -0.01
  • LC 0.10
  • Stochastic Oscillator
  • ABCL 43.84
  • LC 62.82

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About LC LendingClub Corporation

LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.

Share on Social Networks: